Intangible Assets (Tables)

12 Months Ended

Sep. 30, 2012

Thereafter

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Intangible assets at September 30, 2012 and 2011 consist of the following:

	Useful	Gross		Accumulated
September 30, 2012	Life (years)	Amount		Amortization		Net
Acquired Customer Base	5-15	$	7,858,775	$	2,257,533	$	5,601,242
Know How	15		512,000		145,147		366,853
Trade Names	15 - Indefinite		558,435		63,222		495,213
Backlog	4		182,000		182,000		-0-
Biomedical Technologies	5		300,000		60,003		239,997
		$	9,411,210	$	2,707,905	$	6,703,305

	Useful	Gross		Accumulated
September 30, 2011	Life (years)	Amount		Amortization		Net
Acquired Customer Base	5-15	$	7,830,117	$	1,617,596	$	6,212,521
Know How	15		512,000		110,933		401,067
Trade Names	15 - Indefinite		546,240		48,622		497,618
Backlog	4		182,000		126,700		55,300
Biomedical Technologies	5		300,000		-0-		300,000
		$	9,370,357	$	1,903,851	$	7,466,506

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Amortization expense for the years ended September 30, 2012 and 2011 was $802,511 and $596,820 respectively. Estimated amortization expense for each of the next five fiscal years is as follows:

	2013		2014		2015		2016		2017		Thereafter		Total
Acquired Customer Base	$	542,615	$	542,615	$	542,615	$	542,615	$	542,615	$	2,888,167	$	5,601,242
Know How		34,133		34,133		34,133		34,133		34,133	$	196,188		366,853
Trade Names		14,600		14,600		14,600		14,600		14,600	$	422,213		495,213
Biomedical Technologies		60,000		60,000		60,000		59,997		-0-		-0-		239,997
	$	651,348	$	651,348	$	651,348	$	651,345	$	591,348	$	3,506,568	$	6,703,305